Publications
47
Citations
236
Est. group size
~10
Recurring co-author estimate
Active years
12
Publishing since 2014
J. Rosenheck's research centers on lung transplantation, particularly monitoring transplant recipients for organ rejection and infection using tools like donor-derived cell-free DNA (a blood test that detects fragments of DNA from the transplanted organ to catch problems early) and microbiome sequencing of lung fluid. Additional work addresses clinical outcomes such as survival trends, donor lung recovery practices, and complications like DNA damage responses linked to blood cell disorders in patients with telomere biology conditions. This work is largely clinical and translational, aimed at improving how doctors detect and manage complications after lung transplant surgery.
Publication output grew from near zero in 2017-2019 to a peak around 2021 and 2024, with year-to-year fluctuation but sustained activity averaging over 5 papers per year in the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders
Journal of Clinical Investigation · 2025
- Variation in Donation After Circulatory Death Donor Lung Recovery Rates by Organ Procurement Organizations
The Journal of Heart and Lung Transplantation · 2025
- Species Level Identification Via Tiling 16s rRNA Gene Amplicon Sequencing for Microbiome Characterization of Bronchoalveolar Lavage Fluid in Lung Transplant Patients: A Proof-of-Concept Study
American Journal of Respiratory and Critical Care Medicine · 2025
- Plasma Donor-Derived Cell-Free DNA Surveillance Can Direct Safe Reduction in Surveillance Bronchoscopy Procedures During the Initial Year After Lung Transplant
The Journal of Heart and Lung Transplantation · 2024
- Evolving Trends in Underlying Etiologies for Lung Transplantation, Overall Survival, but Not in Freedom From CLAD-BOS
2024
- Do not forget about the left ventricle after lung transplantation for pulmonary hypertension
JHLT Open · 2024
- 263.4: Donor-derived cell-free DNA is a valuable surveillance tool after single lung transplantation: Multi-center analysis.
Transplantation · 2024
- DNA Damage Response Constrains Cell Growth and Drives Clonal Hematopoiesis in Telomere Biology Disorders
Blood · 2023
- Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection
Current Pulmonology Reports · 2022
- Pulmonary hematoidin deposition in a case of severe COVID19 pneumonia
Human Pathology Reports · 2022
- Quantitative Donor-Derived Cell-Free DNA Levels Reflect the Variability in Lung Allograft Cellular Injury
The Journal of Heart and Lung Transplantation · 2022
- Donor-Derived Cell-Free DNA Plus Tissue Gene Expression Profiling of Lung Allograft Injury
The Journal of Heart and Lung Transplantation · 2022
- Metagenomic Next Generation Sequencing (mNGS) Can Complement Fractional Donor-Derived Cell-Free DNA in Lung Allograft Assessment: Pilot Data
The Journal of Heart and Lung Transplantation · 2022
- 427.5: Clinical Validation of a Plasma Donor-Derived Cell-Free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
Transplantation · 2022
- Lung transplantation for pulmonary hypertension
Journal of Thoracic Disease · 2021
- The Journal of Heart and Lung Transplantation×15
- JHLT Open×4
- Current Pulmonology Reports×2
- Journal of Bronchology & Interventional Pulmonology×2
- Clinical Transplantation×2
- David R. Nunley
Medicine · The Ohio State University
- Ervin Y. Cui
Medicine · The Ohio State University
- Divyaam Satija
Medicine · The Ohio State University
- Doug A. Gouchoe
Medicine · The Ohio State University
- Don Hayes
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile